| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S0341 |
Lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage |
1,454 |
876 |
$1.22M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,136 |
839 |
$76K |
| S0340 |
Lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage |
113 |
66 |
$62K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,262 |
318 |
$13K |
| 97116 |
|
500 |
78 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
271 |
78 |
$2K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
253 |
83 |
$804.28 |
| 97542 |
|
65 |
25 |
$665.16 |
| 92526 |
|
33 |
15 |
$555.86 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,136 |
629 |
$247.12 |
| 92610 |
|
13 |
13 |
$211.56 |
| 90688 |
|
114 |
114 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
147 |
147 |
$0.00 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
140 |
98 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
66 |
52 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
135 |
94 |
$0.00 |
| 90756 |
|
33 |
33 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
155 |
127 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
201 |
150 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
90 |
89 |
$0.00 |